首页> 外国专利> METHOD FOR IDENTIFICATION AND EVALUATIION OF OPPORTUNISTIC INFECTIONS AGENTS PATHOGENICITY LEVEL IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR PREDICTION OF COURSE AND DEVELOPMENT OF INFECTIOUS DISEASES COMPLICATIONS

METHOD FOR IDENTIFICATION AND EVALUATIION OF OPPORTUNISTIC INFECTIONS AGENTS PATHOGENICITY LEVEL IN WOMEN OF REPRODUCTIVE AGE AND NEWBORN CHILDREN FOR PREDICTION OF COURSE AND DEVELOPMENT OF INFECTIOUS DISEASES COMPLICATIONS

机译:繁殖年龄和新生儿的机会性感染致病力水平的鉴定和评估方法,以预测和发展感染性疾病的复杂性

摘要

FIELD: medicine.;SUBSTANCE: for women, scrapes of epithelial cells from the vagina (posterolateral arches) and cervical canal, endometrial biopsy, metoaspirate, abscess contents, abdominal exudate, blood, urine are used for the research. For newborns, scrapes from the mucous membranes of the gastrointestinal tract (feces, oropharynx), eye secretions, contents of the vesicles, the umbilical cord, blood, urine, contents of the venous catheter are used for the research. Real time PCR is performed. In the biomaterial samples, the total bacterial mass, the number of genomes of the opportunistic microflora representatives belonging to eleven taxa is determined: Enterobacteriaceae family, genera: Streptococcus, Enterococcus, Staphylococcus, Candida, species: Streptococcus agalactiae, Enterococcus faecalis, Staphylococcus aureus, Escherichia coli, Gardnerella vaginalis , Candida albicans, and the presence of eighteen marker loci associated with the pathogenicity of the main conditionally pathogenic microorganisms: G. vaginalis sialidase, G. vaginalis lacZ, G. vaginalis fucA, S. agalactiae sialidase, S. agalactiae ST-17, S. agalactiae ST -19/23, S. aureus tsst, S. aureus lukS, S. aureus lukF, S. aureus icaA, S. aureus icaD, E. faecalis cy lA, E. faecalis cylB, E. coli cnf1, E. coli vat, E. colipapC, E. coli stx1, E. coli stx2. Depending on the presence/absence of the pathogen, its number and pathogenicity marker genes, an assessment is made of the level of infectious agents pathogenicity and a prognosis of the course and development of disease complications is provided. According to the prognosis, the tactics of patient treatment are implemented.;EFFECT: higher prediction accuracy.;7 tbl, 3 ex
机译:领域:药物;物质:对于女性,研究使用了阴道(后外侧弓)和宫颈管的上皮细胞擦伤,子宫内膜活检,甲氨蝶呤,脓肿内容物,腹部渗出液,血液,尿液。对于新生儿,使用胃肠道粘膜(粪便,口咽),眼分泌物,囊泡含量,脐带,血液,尿液,静脉导管含量的擦拭物进行研究。进行实时PCR。在生物材料样品中,确定细菌总数,属于11个分类群的机会微生物群代表的基因组数目:肠杆菌科,属:链球菌,肠球菌,葡萄球菌,念珠菌,种:无乳链球菌,粪肠球菌,金黄色葡萄球菌大肠杆菌,阴道加德纳菌,白色念珠菌以及与主要条件致病微生物的致病性相关的18个标记基因座的存在:阴道加德纳菌唾液酸酶,阴道加德莱氏菌lacZ,阴道加纳氏菌fucA,无乳链球菌唾液酸酶,无乳链球菌ST-17,无乳链球菌ST -19/23,金黄色葡萄球菌tsst,金黄色葡萄球菌lusS,金黄色葡萄球菌lukF,金黄色葡萄球菌icaA,金黄色葡萄球菌icaD,粪肠球菌cylA,粪肠球菌cylB,E大肠杆菌cnf1,大肠杆菌大桶,大肠杆菌colipapC,大肠杆菌stx1,大肠杆菌stx2。取决于病原体的存在/不存在,其数量和致病性标记基因,评估传染病的致病性水平,并提供病程和疾病并发症的预后。根据预后,实施患者治疗策略。效果:更高的预测准确性。7 tbl,3 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号